Data / Form D filings / Cahaba Pharmaceuticals, LLC
Cahaba Pharmaceuticals, LLC: Form D filings
Cahaba Pharmaceuticals, LLC, a pharmaceuticals company in Princeton, NJ, filed 6 Form D notices with the SEC between 2009 and 2013. The latest, on January 18, 2013, reports $205,000 sold of a $1 million offering.
Find out what Cahaba Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 103 Carnegie Center, Suite 300, Princeton, NJ, 08540
- Phone
- (609) 524-2288
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1460300
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 18, 2013 | New notice | $1,000,000 | $205,000 | $795,000 | 0 | Jan 9, 2013 | sec.gov |
| Mar 22, 2012 | New notice | Indefinite | $250,000 | Indefinite | 1 | Mar 7, 2012 | sec.gov |
| Dec 17, 2010 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
| Oct 28, 2010 | New notice | $1,500,000 | $500,000 | $1,000,000 | 1 | Oct 20, 2010 | sec.gov |
| May 29, 2009 | Amendment | $2,735,023 | $831,959 | $1,903,064 | 0 | Mar 27, 2009 | sec.gov |
| Mar 30, 2009 | New notice | $735,023 | $0 | $735,023 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew P. Aromando | Executive Officer | |
| J. Rainer Twiford | Executive Officer, Director | |
| Madding Rainer King, III | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jan 14, 2013 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cahaba Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.